The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market In 2026 And 2030?
The single-cell expression quantitative trait locus (eqtl) clinical workflows market has experienced rapid expansion in recent years. This market is projected to increase from $1.82 billion in 2025 to $2.18 billion in 2026, reflecting a compound annual growth rate (CAGR) of 19.6%. The historical growth of the market can be ascribed to several factors, including the adoption of bulk sequencing methods, a rise in investment within genomics research, the escalating demand for disease biomarker identification, the presence of limited automation in workflows, and a reliance on manual data analysis.
The single-cell expression quantitative trait locus (eqtl) clinical workflows market size is anticipated to experience rapid expansion in the upcoming years. It is projected to increase to $4.51 billion by 2030, achieving a compound annual growth rate (CAGR) of 19.9%. This growth throughout the forecast period can be attributed to the rise of AI-driven analysis tools, the adoption of single-cell sequencing technologies, the expansion of personalized medicine initiatives, integration with cloud-based platforms, and the automation of sample and library preparation. Prominent trends for the forecast period include single-cell sequencing integration, advanced computational analysis, high-resolution gene expression mapping, automated workflow pipelines, and predictive biomarker discovery.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Affecting The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Demand?
The increasing acceptance of precision medicine is projected to stimulate the expansion of the single-cell expression quantitative trait locus (eQTL) clinical workflows market in the future. Precision medicine is a healthcare approach that customizes disease prevention, diagnosis, and treatment strategies to align with individual patient characteristics, including their genetic makeup, lifestyle, and environment. The growing integration of precision medicine is accelerating due to the escalating worldwide prevalence of complex and chronic illnesses that demand highly specific and individualized treatment methods. Single-cell expression quantitative trait locus (eQTL) clinical workflows support the rising adoption of precision medicine by enabling high-resolution analysis of gene expression variations at the individual cell level, which facilitates the identification of patient-specific therapeutic targets. They also streamline the processing and interpretation of complex genomic data, thereby reducing the time from sample collection to actionable insights, and consequently enhancing personalized treatment strategies and clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition, a US-based educational and advocacy organization, stated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. Therefore, the growing uptake of precision medicine is fueling the growth of the single-cell expression quantitative trait locus (eQTL) clinical workflows market.
How Is The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Broken Down By Segment Categories?
The single-cell expression quantitative trait locus (eQTL) clinical workflows market covered in this report is segmented –
1) By Workflow Type: Sample Preparation, Library Preparation, Sequencing, Data Analysis, Other Workflow Types
2) By Technology: Ribonucleic Acid Sequencing, Microarray, Polymerase Chain Reaction (PCR)-Based, Other Technologies
3) By Application: Disease Research, Drug Discovery And Development, Personalized Medicine, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Sample Preparation: Cell Isolation, Cell Sorting, Cell Lysis, Nucleic Acid Extraction, Quality Control Assessment
2) By Library Preparation: Ribonucleic Acid Fragmentation, Complementary Deoxyribonucleic Acid Synthesis, Adapter Ligation, Amplification, Library Quality Control
3) By Sequencing: Whole Transcriptome Sequencing, Targeted Sequencing, Single Cell Sequencing, High Throughput Sequencing, Paired End Sequencing
4) By Data Analysis: Read Alignment, Expression Quantification, Variant Calling, Expression Quantitative Trait Loci Mapping, Statistical Analysis
5) By Other Workflow Types: Data Integration, Validation Studies, Reporting And Documentation, Regulatory Compliance, Data Storage And Management
What Market Trends Are Affecting The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?
Leading companies in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are concentrating on developing advanced solutions, such as whole genome sequencing (WGS)-based eQTL workflows, to enable precise, cell-type-specific genetic analysis and advance personalized medicine. Whole genome sequencing (WGS)-based eQTL workflows are analytical approaches that integrate whole-genome sequencing data with gene expression data to pinpoint genetic variants that influence gene expression levels. For example, in January 2023, Singleron Biotechnologies Ltd., a Germany-based biotechnology company, unveiled a new single-cell eQTL analysis workflow as part of its sequencing service. This workflow is a bioinformatic pipeline that utilizes scRNA-seq and WGS data to predict cell-type-specific eQTLs, empowering researchers to study the link between genetic variation and gene expression levels with high resolution. This tool is perfectly suited for customers conducting population studies and requiring integrated wet lab and computational support, offering a streamlined solution to clarify the molecular mechanisms of disease and complement Singleron’s established single-cell multi-omics sequencing services.
Which Players Are Present In The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Space?
Major companies operating in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are Thermo Fisher Scientific Inc., Becton Dickinson Company, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Standard BioTools Inc., Singleron Biotechnologies GmbH, Mission Bio Inc., Active Motif Inc., Admera Health LLC, Atrandi Biosciences UAB, SeqWell Inc., S2 Genomics Inc., Honeycomb Biotechnologies Inc., Roche Sequencing Solutions Inc., Cell Microsystems Inc.
Get The Full Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Report:
Which Geographic Region Dominates The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?
North America was the largest region in the single-cell expression quantitative trait locus (eQTL) clinical workflows market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell expression quantitative trait locus (eQTL) clinical workflows market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market 2026, By The Business Research Company
pruritus therapeutic market report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
genomic urine testing market report 2026
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report
ocular genetic diagnostic market report 2026
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model